Theoretical pharmacokinetic advantages and methodological flaws: glargine is not superior to NPH insulin in children with type 1 diabetes mellitus
AUTOR(ES)
Dora, José Miguel, Scheffel, Rafael S.
FONTE
Arquivos Brasileiros de Endocrinologia & Metabologia
DATA DE PUBLICAÇÃO
2010-02
RESUMO
Documentos Relacionados
- Nausea and vomiting due to insulin glargine in patient with type 1 diabetes mellitus
- CHILDREN WITH DIABETES MELLITUS TYPE 1: VULNERABILITY, CARE AND ACCESS TO HEALTH
- Endothelial dysfunction in children with type 1 diabetes mellitus
- Oral health knowledge and habits in children with type 1 diabetes mellitus
- Insulin Is a Stronger Inducer of Insulin Resistance than Hyperglycemia in Mice with Type 1 Diabetes Mellitus (T1DM)*
